Table 2.
Baseline Clinical Characteristics of Analyzed Groups Before (Left Panel) and After Propensity-Matching (Right Panel)
Variable |
Unmatched | Matched | ||||
---|---|---|---|---|---|---|
SAVR n = 4747 |
TAVI n = 439 |
P | SAVR n = 348 |
TAVI n = 348 |
P | |
Age, years, ±SD | 66.5 ± 10.7 | 78.6 ± 7.2 | <.001 | 76.7 ± 6.0 | 77.1 ± 7.2 | .338 |
Prior myocarditis | 3.4% | 4.1% | .554 | 3.7% | 3.7% | .842 |
Prior MI | 10.6% | 21.4% | <.001 | 19.5% | 19.3% | 1.000 |
CCS | 80.7% | 95.0% | <.001 | 94.3% | 94.0% | 1.000 |
Heart failure | 29.9% | 65.2% | <.001 | 62.1% | 58.9% | .438 |
Hypertension | 79.0% | 94.5% | <.001 | 93.4% | 93.1% | 1.000 |
Diabetes | 28.3% | 49.0% | <.001 | 50.6% | 46.6% | .324 |
Hypercholesterolemia | 21.9% | 28.9% | .001 | 28.7% | 26.4% | .553 |
Atrial fibrillation | 12.6% | 30.5% | <.001 | 27.6% | 28.5% | .866 |
Prior pulmonary edema | 2.6% | 6.6% | <.001 | 4.3% | 4.9% | .856 |
COPD | 10.9% | 24.2% | <.001 | 23.0% | 22.4% | .928 |
Chronic kidney disease | 3.4% | 9.6% | <.001 | 7.8% | 7.8% | .887 |
Cancer | 23.1% | 38.3% | <.001 | 39.7% | 35.6% | .309 |
Prior stroke | 4.4% | 13.4% | <.001 | 10.6% | 9.5% | .705 |
CCS, chronic coronary syndrome; COPD, chronic obstructive pulmonary disease; MI, myocardial infarction; SAVR, surgical aortic valve replacement; SD, standard deviation; TAVI, transcatheter aortic valve implantation.